Cipher Pharma (CPHR) Tops Q4 EPS by 8c

Cipher Pharma (NASDAQ: CPHR) reported Q4 EPS of $0.08, $0.08 better than the analyst estimate of $0.00. Revenue for the quarter came in at $9.7 million versus the consensus estimate of $9.31 million.

For earnings history and earnings-related data on Cipher Pharma (CPHR) click here.

You May Also Be Interested In

• Goldman Regional Director in US Adjusts List of Top Names
• Macquarie Upgrades Kyocera (6971:JP) (KYOCY) to Outperform
• Raymond James Upgrades CVB Financial (CVBF) to Outperform